Journal
JOURNAL OF TOXICOLOGY-CLINICAL TOXICOLOGY
Volume 41, Issue 6, Pages 831-839Publisher
MARCEL DEKKER INC
DOI: 10.1081/CLT-120025348
Keywords
N,N-diethyl-m-toluamide; DEET; toxicology; epidemiology; toxicodynamics; pharmacokinetics; risk assessment
Categories
Ask authors/readers for more resources
The emergence of West Nile Virus (WNV) in North America has resulted in increased public awareness and utilization of insect repellents containing N,N-diethyl-m-toluamide (DEET) in the prevention of mosquito-borne disease. Regulatory reassessments in North American countries have recently been completed for insect repellents containing DEFT as active ingredient, resulting in labeling changes intended to minimize unnecessary exposure to special populations, including children. This article describes those changes, and summarizes more recent data relating to the pharmacokinetics, toxicology, and epidemiology of adverse effects associated with DEET in humans.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available